Nuñez, Debeth .
HRN: 23-87-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2023
CEFUROXIME 1.5GM (VIAL)
12/04/2023
12/11/2023
IV
1.5g As LD Then 750mg
Q8
Stat CS
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes